159 related articles for article (PubMed ID: 38715023)
1. Impact of acute glycemic variability on short-term outcomes in patients with ST-segment elevation myocardial infarction: a multicenter population-based study.
Wang J; Wang LL; Yang YM; Tan HQ; Zhu J
Cardiovasc Diabetol; 2024 May; 23(1):155. PubMed ID: 38715023
[TBL] [Abstract][Full Text] [Related]
2. Impact of glycemic gap on 30-day adverse outcomes in patients with acute ST-segment elevation myocardial infarction.
Wu S; Yang YM; Zhu J; Xu W; Wang LL; Lyu SQ; Wang J; Shao XH; Zhang H
Atherosclerosis; 2022 Nov; 360():34-41. PubMed ID: 36265428
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.
Zhao X; Wang Y; Chen R; Li J; Zhou J; Liu C; Zhou P; Sheng Z; Chen Y; Song L; Zhao H; Yan H
Cardiovasc Diabetol; 2021 Jun; 20(1):131. PubMed ID: 34183007
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction: insights from a multi-center observational study.
Xu W; Yang YM; Zhu J; Wu S; Wang J; Zhang H; Shao XH
Cardiovasc Diabetol; 2022 Mar; 21(1):48. PubMed ID: 35351149
[TBL] [Abstract][Full Text] [Related]
5. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
[TBL] [Abstract][Full Text] [Related]
6. The role of late reperfusion in ST-segment elevation myocardial infarction: a real-world retrospective cohort study.
Guo Q; Huang J; Shen Y; Tong G; Li H; Meng S
BMC Cardiovasc Disord; 2020 Apr; 20(1):207. PubMed ID: 32345243
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle mass is associated with glycemic variability in patients with ST-segment elevation myocardial infarction.
Gohbara M; Iwahashi N; Sato R; Akiyama E; Konishi M; Nakahashi H; Kataoka S; Takahashi H; Kirigaya J; Minamimoto Y; Okada K; Matsuzawa Y; Maejima N; Hibi K; Kosuge M; Ebina T; Sugano T; Ishikawa T; Tamura K; Kimura K
Heart Vessels; 2021 Jul; 36(7):945-954. PubMed ID: 33492437
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical outcomes and left ventricular remodeling after ST-elevation myocardial infarction between patients with and without diabetes mellitus.
Akashi N; Tsukui T; Yamamoto K; Seguchi M; Taniguchi Y; Sakakura K; Wada H; Momomura SI; Fujita H
Heart Vessels; 2021 Oct; 36(10):1445-1456. PubMed ID: 33715109
[TBL] [Abstract][Full Text] [Related]
9. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI.
Yang CD; Shen Y; Ding FH; Yang ZK; Hu J; Shen WF; Zhang RY; Lu L; Wang XQ
Cardiovasc Diabetol; 2020 Sep; 19(1):131. PubMed ID: 32878604
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impacts of diabetes status and lipoprotein(a) levels in patients with ST-segment elevation myocardial infarction: a prospective cohort study.
Li N; Zhou J; Chen R; Zhao X; Li J; Zhou P; Liu C; Chen Y; Wang Y; Song L; Yan S; Zhao H; Yan H
Cardiovasc Diabetol; 2023 Jun; 22(1):151. PubMed ID: 37365608
[TBL] [Abstract][Full Text] [Related]
11. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction.
Zhang Y; Ding X; Hua B; Liu Q; Gao H; Chen H; Zhao XQ; Li W; Li H
Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2351-2362. PubMed ID: 32917496
[TBL] [Abstract][Full Text] [Related]
12. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.
Falkentoft AC; Rørth R; Iversen K; Høfsten DE; Kelbæk H; Holmvang L; Frydland M; Schoos MM; Helqvist S; Axelsson A; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Pedersen F; Torp-Pedersen C; Kofoed KF; Goetze JP; Engstrøm T; Køber L
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776961
[TBL] [Abstract][Full Text] [Related]
13. Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients.
Sia CH; Chan MH; Zheng H; Ko J; Ho AF; Chong J; Foo D; Foo LL; Lim PZ; Liew BW; Chai P; Yeo TC; Tan HC; Chua T; Chan MY; Tan JWC; Bulluck H; Hausenloy DJ
Cardiovasc Diabetol; 2021 Oct; 20(1):211. PubMed ID: 34666746
[TBL] [Abstract][Full Text] [Related]
14. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
Luo E; Wang D; Yan G; Qiao Y; Liu B; Hou J; Tang C
Cardiovasc Diabetol; 2019 Nov; 18(1):150. PubMed ID: 31722708
[TBL] [Abstract][Full Text] [Related]
15. Discharge Hemoglobin Association with Long-Term Outcomes of ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.
Gao M; Zhang X; Qin L; Zheng Y; Zhang Z; Tong Q; Li H
Cardiovasc Ther; 2020; 2020():8647837. PubMed ID: 32190122
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes.
Rokicka D; Hudzik B; Wróbel M; Stołtny T; Stołtny D; Nowowiejska-Wiewióra A; Rokicka S; Gąsior M; Strojek K
Cardiovasc Diabetol; 2024 Apr; 23(1):147. PubMed ID: 38685054
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction.
Qin Y; Yan G; Qiao Y; Wang D; Luo E; Hou J; Tang C
BMC Cardiovasc Disord; 2020 Feb; 20(1):95. PubMed ID: 32103724
[TBL] [Abstract][Full Text] [Related]
18. Admission macrophage migration inhibitory factor predicts long-term prognosis in patients with ST-elevation myocardial infarction.
Deng XN; Wang XY; Yu HY; Chen SM; Xu XY; Huai W; Liu GH; Ma QB; Zhang YY; Dart AM; Du XJ; Gao W
Eur Heart J Qual Care Clin Outcomes; 2018 Jul; 4(3):208-219. PubMed ID: 29726987
[TBL] [Abstract][Full Text] [Related]
19. The diagonal branches and outcomes in patients with anterior ST- elevation myocardial infarction.
Zhang S; Deng X; Yang W; Xia L; Yao K; Lu H; Ge L; Shen L; Sun A; Zou Y; Qian J; Ge J
BMC Cardiovasc Disord; 2020 Mar; 20(1):108. PubMed ID: 32131738
[TBL] [Abstract][Full Text] [Related]
20. Day-to-day fasting plasma glucose variability on the short-term prognosis of ST-segment elevation myocardial infarction: A retrospective cohort study.
Yi M; Cao Q; Tang WH; Liu Q; Ke X
Clin Cardiol; 2022 Dec; 45(12):1246-1254. PubMed ID: 36069119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
